doi: 10.1086/652237.
The 10 x '20 Initiative: pursuing a global commitment to develop 10 new antibacterial drugs by 2020
Collaborators,
Affiliations
- PMID: 20214473
- DOI: 10.1086/652237
Item in Clipboard
The 10 x '20 Initiative: pursuing a global commitment to develop 10 new antibacterial drugs by 2020
Clin Infect Dis.
.
Abstract
The time has come for a global commitment to develop new antibacterial drugs. Current data document the impending disaster due to the confluence of decreasing investment in antibacterial drug research and development concomitant with the documented rapid increase in the level of resistance to currently licensed drugs. Despite the good faith efforts of many individuals, professional societies, and governmental agencies, the looming crisis has only worsened over the past decade.
Comment in
-
Questions about the 10 x '20 Initiative.Clin Infect Dis. 2010 Sep 15;51(6):751-2; author reply 754-5. doi: 10.1086/655955. Clin Infect Dis. 2010. PMID: 20731566 No abstract available.
-
Development of new antibacterials: a laudable aim, but what is the value?Clin Infect Dis. 2010 Sep 15;51(6):752-3; author reply 754-5. doi: 10.1086/655956. Clin Infect Dis. 2010. PMID: 20731567 No abstract available.
-
Letter in response to the Infectious Diseases Society of America's 10 x '20 Initiative.Clin Infect Dis. 2010 Sep 15;51(6):753; author reply 754-5. doi: 10.1086/655957. Clin Infect Dis. 2010. PMID: 20731568 No abstract available.
Similar articles
-
Antibacterial resistance: is there a way out of the woods?Future Microbiol. 2011 Jul;6(7):707-9. doi: 10.2217/fmb.11.56. Future Microbiol. 2011. PMID: 21797683 No abstract available.
-
Questions about the 10 x '20 Initiative.Clin Infect Dis. 2010 Sep 15;51(6):751-2; author reply 754-5. doi: 10.1086/655955. Clin Infect Dis. 2010. PMID: 20731566 No abstract available.
-
Coping with antibiotic resistance: the impending crisis.Int J Antimicrob Agents. 2010 Nov;36 Suppl 3:S1-2. doi: 10.1016/S0924-8579(10)00497-8. Int J Antimicrob Agents. 2010. PMID: 21129626 Review.
-
Letter in response to the Infectious Diseases Society of America's 10 x '20 Initiative.Clin Infect Dis. 2010 Sep 15;51(6):753; author reply 754-5. doi: 10.1086/655957. Clin Infect Dis. 2010. PMID: 20731568 No abstract available.
-
Update on the antibacterial resistance crisis.Med Sci Monit. 2007 Jun;13(6):RA103-18. Med Sci Monit. 2007. PMID: 17534243 Review.
Cited by
-
Development of new drugs for an old target: the penicillin binding proteins.Molecules. 2012 Oct 24;17(11):12478-505. doi: 10.3390/molecules171112478. Molecules. 2012. PMID: 23095893 Free PMC article. Review.
-
Assessment of Quality Indicators for Appropriate Antibiotic Use.Antimicrob Agents Chemother. 2018 Nov 26;62(12):e00875-18. doi: 10.1128/AAC.00875-18. Print 2018 Dec. Antimicrob Agents Chemother. 2018. PMID: 30249698 Free PMC article.
-
Identification of Small Molecules Exhibiting Oxacillin Synergy through a Novel Assay for Inhibition of vraTSR Expression in Methicillin-Resistant Staphylococcus aureus.Antimicrob Agents Chemother. 2019 Aug 23;63(9):e02593-18. doi: 10.1128/AAC.02593-18. Print 2019 Sep. Antimicrob Agents Chemother. 2019. PMID: 31209003 Free PMC article.
-
Future Challenges in Pediatric and Neonatal Sepsis: Emerging Pathogens and Antimicrobial Resistance.J Pediatr Intensive Care. 2019 Mar;8(1):17-24. doi: 10.1055/s-0038-1677535. Epub 2019 Jan 17. J Pediatr Intensive Care. 2019. PMID: 31073504 Free PMC article. Review.
-
Discovery of 4,6-bis(2-((E)-benzylidene)hydrazinyl)pyrimidin-2-Amine with Antibiotic Activity.ChemistryOpen. 2019 Jul 4;8(7):896-907. doi: 10.1002/open.201800241. eCollection 2019 Jul. ChemistryOpen. 2019. PMID: 31312589 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
